BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, ...
The Heard and McDonald Islands are among the dozens of targets of President Donald Trump's latest round of tariffs. But they ...
Dr. Laila El-Khattabi (Sorbonne University Hospitals and the Brain Institute, Paris, France) will share results from the CHROMAPS project, a multi-institutional European collaboration utilizing OGM to ...
HYDRA-PMCF-study evaluated hygh-tec®, a new polyurethane fecal management systemhygh-tec® showed a high level of sealing performance (no leakage ...
Interested contributors have until 2 May 2025 to submit abstracts for scientific posters ... medical physicists, medical radiation technologists and regulatory authorities. Contributors interested in ...
In this post-hoc analysis of ATTRibute-CM, incremental increases in serum TTR levels on Day 28, achieved with acoramidis, may independently predict greater reduction in risks of cardiovascular ...
Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that ...
Compared with those who spent most of their time in a single room, people with heart failure with preserved ejection fraction ...
Almirall, a global pharmaceutical company dedicated to medical dermatology hosts the 16th edition of Skin Academy, a premier conference for healthcare professionals in the field of dermatology. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback